Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70676 - 70700 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	G0S2	50486	upregulated	Silicon Dioxide results in increased expression of G0S2 mRNA	1q32.2	A24197 A24196
Silicon dioxide	Approved	G6PD	2539	downregulated	Silicon Dioxide analog results in decreased expression of G6PD mRNA	Xq28	A24195
Silicon dioxide	Approved	GAA	2548	downregulated	Silicon Dioxide analog results in decreased expression of GAA mRNA	17q25.3	A24195
Silicon dioxide	Approved	GAB1	2549	upregulated	Silicon Dioxide results in increased expression of GAB1 mRNA	4q31.21	A24196
Silicon dioxide	Approved	GABPB1	2553	upregulated	Silicon Dioxide analog results in increased expression of GABPB1 mRNA	15q21.2	A24195
Silicon dioxide	Approved	GABRA5	2558	upregulated	Silicon Dioxide analog results in increased expression of GABRA5 mRNA	15q12	A24195
Silicon dioxide	Approved	GADD45A	1647	upregulated	Silicon Dioxide analog results in increased expression of GADD45A mRNA	1p31.3	A24195
Silicon dioxide	Approved	GADD45B	4616	upregulated	Silicon Dioxide results in increased expression of GADD45B mRNA	19p13.3	A24196
Silicon dioxide	Approved	GADD45G	10912	upregulated	Silicon Dioxide results in increased expression of GADD45G mRNA	9q22.2	A24196
Silicon dioxide	Approved	GAL	51083	upregulated	Silicon Dioxide analog results in increased expression of GAL mRNA	11q13.2	A24194 A24195
Silicon dioxide	Approved	GAL3ST1	9514	downregulated	Silicon Dioxide analog results in decreased expression of GAL3ST1 mRNA	22q12.2	A24195
Silicon dioxide	Approved	GALE	2582	upregulated	Silicon Dioxide analog results in increased expression of GALE mRNA	1p36.11	A24195
Silicon dioxide	Approved	GALM	130589	downregulated	Silicon Dioxide analog results in decreased expression of GALM mRNA	2p22.1	A24195
Silicon dioxide	Approved	GALNT12	79695	downregulated	Silicon Dioxide analog results in decreased expression of GALNT12 mRNA	9q22.33	A24194 A24195
Silicon dioxide	Approved	GALNT13	114805	upregulated	Silicon Dioxide analog results in increased expression of GALNT13 mRNA	2q23.3-q24.1	A24195
Silicon dioxide	Approved	GALNT4	8693	downregulated	Silicon Dioxide analog results in decreased expression of GALNT4 mRNA	12q21.33	A24195
Silicon dioxide	Approved	GALNT9	50614	upregulated	Silicon Dioxide analog results in increased expression of GALNT9 mRNA	12q24.33	A24195
Silicon dioxide	Approved	GALP	85569	upregulated	Silicon Dioxide analog results in increased expression of GALP mRNA	19q13.43	A24194
Silicon dioxide	Approved	GALT	2592	downregulated	Silicon Dioxide results in decreased expression of GALT mRNA	9p13.3	A24196
Silicon dioxide	Approved	GAR1	54433	upregulated	Silicon Dioxide analog results in increased expression of GAR1 mRNA	4q25	A24195
Silicon dioxide	Approved	GAREM1	64762	downregulated	Silicon Dioxide analog results in decreased expression of GAREM1 mRNA	18q12.1	A24195
Silicon dioxide	Approved	GARNL3	84253	upregulated	Silicon Dioxide analog results in increased expression of GARNL3 mRNA	9q33.3	A24195
Silicon dioxide	Approved	GAS1	2619	downregulated	Silicon Dioxide results in decreased expression of GAS1 mRNA	9q21.33	A24197 A24196
Silicon dioxide	Approved	GAS6	2621	downregulated	Silicon Dioxide analog results in decreased expression of GAS6 mRNA	13q34	A24195
Silicon dioxide	Approved	GATA5	140628	upregulated	Silicon Dioxide analog results in increased expression of GATA5 mRNA	20q13.33	A24195

Displaying entries 70676 - 70700 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability